bibliographicCitation |
Abrahamian H, Francesconi M, Loiskandl A, Dzien A, Prager R, Weitgasser R. Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring. Diabetes Technol Ther. 2004 Feb;6(1):31–7. doi: 10.1089/152091504322783387. PMID: 15000767. |